Financial Highlights FY 2025-26

  • Revenue from Operations: ₹857.28 crores (Previous Year: ₹801.49 crores), representing growth of approximately 7%
  • Pre-tax Profit after Exceptional Items: ₹82.56 crores (Previous Year: ₹108.33 crores)
  • Exceptional Items: Negative ₹407.45 lakhs (Previous Year: ₹1,390.66 lakhs)
  • Earnings per Share (EPS): ₹46.48 (Previous Year: ₹57.79)
  • Free Cash Balance: Approximately ₹900 crores as at March 31, 2026

The decline in profit was primarily attributed to lower profit reported by Protective Devices Division due to loss of Institutional/Tender business, particularly from USAID.

Strategic Transaction

  • Definitive agreements entered into with Wipro Enterprises Private Limited for sale of EVA and Good Home brands
  • Consideration: ₹256 crores plus applicable GST
  • Transaction closing subject to fulfilment of 'conditions precedent' customary in such transactions
  • Combined turnover of these brands for FY 2025-26: ₹148 crores

Business Division Performance & Outlook

Consumer Products Business (CPD)

  • Reported static performance in FY25-26
  • Woodward's Gripe Water faced volume declines in Southern markets
  • Strong growth in e-Commerce and Modern Trade channels
  • Launched "I Am Woodward's Baby" campaign and Woodward's Tummy Roll-On
  • FY26-27 Strategy: New communication platform, launch of Tummy Tonic in Tamil Nadu, wider distribution of Tummy Roll-On

Animal Welfare Business (AWD)

  • Revenue growth of approximately 12% driven by stronger second-half performance
  • Bovianim, Gallus and Aquanim recorded robust growth; Companim grew 5%
  • FY26-27 Focus: Strengthening flagship brands, bifurcating Bovianim business, expanding e-commerce and retail channels

Medical Devices Business

  • Heart Valve Division: Revenue growth of approximately 2%. CardiaMed Bi-Leaflet Valves supply impacted by Russia-Ukraine conflict. Pilot study of improved TC2 TTK Chitra Titanium Heart Valve completed with encouraging three-year results. Pivotal studies for 400 patients planned subject to funding and regulatory approvals.
  • Ortho Division: Strong revenue growth of 27%. Pilot launch of Citius Fixed Bearing Knee Implant received encouraging response. TiN-coated implants and Hip Implants portfolio delivered healthy growth.
  • FY26-27 Focus: Nationwide rollout of Citius, expansion of field force, launch of Revision Hip Implant System and TiN-Coated Fortius Fixed Bearing Knee Implants

Protective Devices Business

  • Revenue growth of approximately 5%
  • Recovered through new customer additions despite cessation of USAID business and absence of long-term UNFPA agreement
  • Retained WHO-UNFPA pre-qualified supplier status
  • FY26-27 Focus: Strengthening contract manufacturing partnerships, expanding into new geographies, commencing lubricant manufacturing at Virudhunagar facility

Pleasure Products Business

  • Comprises Skore Pleasure Products, MsChief, and Love Depot
  • FY25-26 was year of consolidation and capability building
  • Skore Pleasure Products delivered healthy growth driven by e-commerce and quickcommerce
  • MsChief recorded strong growth through e-commerce and quick-commerce channels
  • Love Depot reported nominal revenue growth with improved marketing efficiency
  • FY26-27 Focus: Portfolio expansion, product innovation, brand building, and deeper consumer engagement

Foods Business

  • Revenue growth of 14%
  • Four new products commercialized from Hosakote R&D Centre
  • Increased focus on protein-rich and health-oriented offerings
  • Jaipur and Hosakote plants received Non-GMO Project Verified Certification for one product each
  • FY26-27 Focus: Maximizing production, optimizing product mix through exports and institutional business, launching innovative products

Dividend Declaration

  • Directors recommend dividend of ₹10.00 per share (100%) for FY25-26
  • Maintains same dividend rate as previous year (₹10.00 per share)

Outlook for 2026-27

  • Overall outlook appears positive considering developments and initiatives
  • Geopolitical instability and West Asia Crisis noted as potential headwinds

Tribute

  • Board paid tribute to Late Mr. T T Jagannathan, Former Chairman, who passed away on October 09, 2025
  • Acknowledged his nearly four decades of association and invaluable contributions to company growth